CLDF Title
Home | Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Reuters Health Information (2007-12-03): Fluoroscopy plus CT allows real-time evaluation of liver shunt placement

Drug & Device Development

Fluoroscopy plus CT allows real-time evaluation of liver shunt placement

Last Updated: 2007-12-03 10:40:22 -0400 (Reuters Health)

CHICAGO (Reuters Health) - A technique using a liver shunt to treat portal hypertension was first tested just 2 weeks ago and reported here by investigators at the University of Virginia in Charlottesville.

The technique combines two older technologies, fluoroscopy and computed tomography (CT), and also uses a free-moving "C-arm" to allow easy access to the patient from nearly any direction. It has the ability to provide imaging throughout the procedure.

The surgeon involved in the procedure was Dr. John Angle, who described it in an interview with Reuters Health during the ongoing 93rd scientific assembly of the Radiology Society of North America.

Dr. Angle and his colleagues have already used rotational digital acquisition technology to facilitate accurate percutaneous kidney access for successful percutaneous nephrolithotripsy in more than 50 patients.

Dr. Angle found that portions of the stones were in a different calyx than expected on the planar images in 11% of patients, and rotational digital CT provided additional information in fully half of the patients.

"CT provides soft tissue information that has always been available separately, before a procedure is done. Now, we can stop and get these images periodically during the procedure within a matter of minutes," Dr. Angle explained.

On November 14th, the procedure was used for the first time in this country when Dr. Angle placed a hepatic shunt in a patient with portal hypertension to decompress blood vessels.

"I see our field being made safer by fusing these multiple modalities to perform more minimally invasive procedures," Dr. Angle stated. "We could use it during chemoembolism, when we're injecting chemotherapy into the liver vessels in patients with liver cancer, and in a variety of other settings, including angiography and any settings in which fluoroscopy would be used."

Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2017 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.